CIDRAP newsletters options
(CIDRAP News) – An advisory committee today called on the Department of Health and Human Services (HHS) to be ready to respond quickly to safety concerns that may emerge during this fall's novel H1N1 influenza vaccination campaign.
(CIDRAP News) A White House expert advisory group today released a report calling for the Obama Administration to accelerate novel H1N1 vaccination preparation for high-risk Americans and appoint a White House pandemic preparedness point person, among other recommendations.
(CIDRAP News) – Federal health officials today said the first results of novel H1N1 vaccine trials—needed for determining the number and size of doses people will get—are expected in mid-September.
Two trials in adult and elderly volunteers started Aug 7 and are now almost fully enrolled, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), at a press teleconference.
(CIDRAP News) The World Health Organization (WHO) yesterday released new guidelines for using antivirals to treat patients with novel H1N1 influenza infections, signaling a shift toward reserving the medications for people with severe infections and those at high risk for complications.
Another large insurer vows to cover H1N1 vaccine administration
Americans not worried about H1N1 but will get vaccine
(CIDRAP News) Federal education and health officials today unveiled updated guidance to help colleges, universities, and other institutions prepare for the return of the novel H1N1 influenza virus to campuses this fall, where school administrators may face difficult challenges.
Aug 19, 2009
(CIDRAP News) Federal officials today released new guidance to help businesses prepare for an expected resurgence of novel H1N1 activity during the upcoming influenza season, a document that clarifies how long sick workers should stay home and suggests ways to keep employees safe and business disruptions at a minimum.
(CIDRAP News) Half a century ago, scientists reported evidence of some curious behavior by the immune system in humans and animals: If a host was exposed to an influenza virus and later encountered a variant strain of the same virus, the immune system responded to the second attack largely with the same weapons it used against the first one.
August 18, 2009
(CIDRAP News) – The US Food and Drug Administration (FDA) today approved a vaccine filling and packaging facility in Illinois owned by CSL Biotherapies, one of the five companies under contract to make novel H1N1 vaccines for the United States, the company announced.
August 17, 2009
(CIDRAP News) Federal officials today during a pandemic H1N1 planning update dialed back the number of novel flu vaccine doses they expect in October from 120 million to 45 million, listing several reasons for the smaller projection.
August 14, 2009
CDC reports 41 more US flu deaths
Aug 13, 2009
(CIDRAP News) On the second and final day of an Institute of Medicine (IOM) task force meeting on how to protect healthcare workers from the novel H1N1 virus, experts focused on issues surrounding the effectiveness and practical use of masks and respirators in work settings.
The IOM task force's goal is to make recommendations about how to protect healthcare workers during the H1N1 pandemic.
It's my job to stay current--even anticipate--what the world of pandemic influenza will look like over the next months. But you will never hear me predict severity. Never. You deserve better than that! The severity of past pandemics predicts nothing about the current pandemic. Worse, it distracts our attention from what we must do right now.
Officials close schools in Bombay
(CIDRAP News) A task force of the Institute of Medicine (IOM), charged with making recommendations about how to protect healthcare workers against novel H1N1 influenza, today heard a variety of evidence that respirators and masks can shield healthcare workers (HCWs) and others from getting respiratory illnesses.
